Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 4 | Rare Historical Photos

3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Barchart

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

Barchart

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

Barchart

How reigning DTM champion Mirko Bortolotti’s Abt switch is going

They were fierce title rivals last year, but Mirko Bortolotti has brought the coveted number one to the Abt DTM team for 2025, following title success last year.

Autosport

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

From soup cans to airplanes, steel and aluminum are a fundamental part of American life

Steel and aluminum are ubiquitous in Americans’ lives

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Abbott Laboratories Stock?

Abbott Laboratories has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

3 Healthcare Stocks Addressing Aging Population Needs

The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased healthcare spending. Hence, investors might consider investing in healthcare stocks, such as UnitedHealth Group (UNH), Abbott Laboratories (ABT), and Medtronic (MDT), which address the needs of the aging population. Read more….

StockNews.com

Mortara linked to DTM comeback with Lamborghini

Edoardo Mortara is poised for a return to the DTM in 2025, six years after his last season in the category, Autosport understands.

Autosport

3 Healthcare IT Stocks Driving Digital Transformation

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and promoting personalized care, making it a promising investment sector. Therefore, strong healthcare IT stocks like Medtronic (MDT), Abbott Laboratories (ABT), and Embecta (EMBC) could be wise additions to your portfolio. Read more.

StockNews.com

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

MarketBeat

Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

Assam STF arrests 2 more Ansarullah Bangla Team members

The Special Task Force (STF) of the Assam Police arrested two more members of the Ansarullah Bangla Team (ABT), said Assam police. Read further on Dynamite News:

Barchart

Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

Autosport

Autosport Top 50 of 2024: #38 Kelvin van der Linde

In his final year racing an Audi, Kelvin van der Linde put together an excellent DTM campaign but came up short to Mirko Bortolotti after leading into the final race.

Autosport

Abt announces Kelvin van der Linde departure ahead of likely BMW move

Abt Sportsline has announced its split with Kelvin van der Linde ahead of his anticipated switch to BMW.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

StockNews.com

3 MedTech Innovators Revolutionizing Patient Care

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

StockNews.com

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Autosport

Kelvin van der Linde set to join BMW, but could be left without DTM seat

GT racing star Kelvin van der Linde is poised to join BMW’s factory roster in 2025, but any such deal would leave him without a seat in the DTM.

Autosport

Five things to watch out for in the new Formula E season

The Christmas decorations might be going up and the wider motorsport world is preparing for its winter hiatus, but Formula E is set to start its new season in Sao Paolo this weekend.

Barchart

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

1 … 3 4 5 6

People

Sheldon van der Linde

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.